Previously treated cases tested for RR-/MDR-TB in Switzerland
Switzerland: Previously treated cases tested for RR-/MDR-TB was 48.0% in 2024. ▼ Falling
Previously treated cases tested for RR-/MDR-TB in Switzerland, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Switzerland recorded 48.0% for previously treated cases tested for rr-/mdr-tb in 2024.
That represents a change of up 2.1% on the previous year and down 31.4% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Switzerland peaked at 89.0% in 2006 and was at its lowest, 0.0%, in 2020.
Switzerland ranks 153rd of 180 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 61.0% | — |
| 2006 | 89.0% | +45.9% |
| 2007 | 71.0% | -20.2% |
| 2008 | 64.0% | -9.9% |
| 2009 | 80.0% | +25.0% |
| 2010 | 82.0% | +2.5% |
| 2011 | 74.0% | -9.8% |
| 2012 | 66.0% | -10.8% |
| 2013 | 73.0% | +10.6% |
| 2014 | 70.0% | -4.1% |
| 2015 | 61.0% | -12.9% |
| 2016 | 50.0% | -18.0% |
| 2017 | 35.0% | -30.0% |
| 2018 | 60.0% | +71.4% |
| 2019 | 73.0% | +21.7% |
| 2020 | 0.0% | -100.0% |
| 2021 | 88.0% | — |
| 2022 | 0.0% | -100.0% |
| 2023 | 47.0% | — |
| 2024 | 48.0% | +2.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 73.0% | 61.0% | 89.0% | 5 |
| 2010s | 64.4% | 35.0% | 82.0% | 10 |
| 2020s | 36.6% | 0.0% | 88.0% | 5 |
Countries ranked near Switzerland
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Heat deaths vs projected death rates 1,104 (2090)
- Un projection of annual infant deaths 46 (2100)
- Population ages 0-14, total, annual growth rate 0.5095 % change on previous year (2025)
- Population ages 0-14, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, total, per capita 0.1488 units per person (2025)
- Population ages 15-64, female, annual growth rate 0.4153 % change on previous year (2025)
- Population ages 15-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, female, per capita 0.3194 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Switzerland?
- Previously treated cases tested for rr-/mdr-tb in Switzerland was 48.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Switzerland?
- The highest recorded value was 89.0% in 2006.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Switzerland?
- The lowest recorded value was 0.0% in 2020.
- How does Switzerland rank for previously treated cases tested for rr-/mdr-tb?
- Switzerland ranks 153rd out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Switzerland?
- Over the last ten years it is down 31.4%. The long-run trend across the full record is falling.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).